Literature DB >> 19131556

TLR-mediated immune activation in HIV.

J Judy Chang1, Marcus Altfeld.   

Abstract

Year:  2009        PMID： 19131556     DOI： 10.1182/blood-2008-10-184598

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  10 in total

1.  Pretreatment levels of soluble cellular receptors and interleukin-6 are associated with HIV disease progression in subjects treated with highly active antiretroviral therapy.

Authors:  Robert C Kalayjian; Rhoderick N Machekano; Nesrine Rizk; Gregory K Robbins; Rajesh T Gandhi; Benigno A Rodriguez; Richard B Pollard; Michael M Lederman; Alan Landay
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

2.  Quantitative theory of entropic forces acting on constrained nucleotide sequences applied to viruses.

Authors:  Benjamin D Greenbaum; Simona Cocco; Arnold J Levine; Rémi Monasson
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-17       Impact factor: 11.205

3.  Differential regulation of toll-like receptor pathways in acute and chronic HIV-1 infection.

Authors:  J Judy Chang; Aurore Lacas; Robert J Lindsay; Erin H Doyle; Karen L Axten; Florencia Pereyra; Eric S Rosenberg; Bruce D Walker; Todd M Allen; Marcus Altfeld
Journal:  AIDS       Date:  2012-03-13       Impact factor: 4.177

4.  Exposure to HIV-1-encoded Toll-like receptor 8 ligands enhances monocyte response to microbial encoded Toll-like receptor 2/4 ligands.

Authors:  Marianne W Mureith; J Judy Chang; Jeffrey D Lifson; Thumbi Ndung'u; Marcus Altfeld
Journal:  AIDS       Date:  2010-07-31       Impact factor: 4.177

5.  Polymorphisms in interferon regulatory factor 7 reduce interferon-α responses of plasmacytoid dendritic cells to HIV-1.

Authors:  Judy Chang; Robert J Lindsay; Smita Kulkarni; Jeffrey D Lifson; Mary Carrington; Marcus Altfeld
Journal:  AIDS       Date:  2011-03-13       Impact factor: 4.177

6.  Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1.

Authors:  Angela Meier; J Judy Chang; Ellen S Chan; Richard B Pollard; Harlyn K Sidhu; Smita Kulkarni; Tom Fang Wen; Robert J Lindsay; Liliana Orellana; Donna Mildvan; Suzane Bazner; Hendrik Streeck; Galit Alter; Jeffrey D Lifson; Mary Carrington; Ronald J Bosch; Gregory K Robbins; Marcus Altfeld
Journal:  Nat Med       Date:  2009-07-13       Impact factor: 53.440

7.  A role for TLR signaling during B cell activation in antiretroviral-treated HIV individuals.

Authors:  Basile Siewe; Ali Keshavarzian; Audrey French; Patricia Demarais; Alan Landay
Journal:  AIDS Res Hum Retroviruses       Date:  2013-08-16       Impact factor: 2.205

Review 8.  "Fusion and binding inhibition" key target for HIV-1 treatment and pre-exposure prophylaxis: targets, drug delivery and nanotechnology approaches.

Authors:  Tanushree Malik; Gaurav Chauhan; Goutam Rath; R S R Murthy; Amit K Goyal
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

9.  HIV-induced immune activation: pathogenesis and clinical relevance - summary of a workshop organized by the German AIDS Society (DAIG e.v.) and the ICH Hamburg, Hamburg, Germany, November 22, 2008.

Authors:  Hans-Jürgen Stellbrink; S Baldus; G Behrens; J R Bogner; T Harrer; C Hoffmann; J van Lunzen; J Münch; P Racz; C Scheller; M Stoll; K Tenner-Racz; J Rockstroh
Journal:  Eur J Med Res       Date:  2010-01-29       Impact factor: 2.175

10.  Thirty Years with HIV Infection-Nonprogression Is Still Puzzling: Lessons to Be Learned from Controllers and Long-Term Nonprogressors.

Authors:  Julie C Gaardbo; Hans J Hartling; Jan Gerstoft; Susanne D Nielsen
Journal:  AIDS Res Treat       Date:  2012-05-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.